Cinta Pallarés
Hospital de Sant Pau · 43 works · 7,038 citations · h-index 14
Top works
- Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial
- Phase III Study Comparing Cisplatin Plus Fluorouracil to Paclitaxel, Cisplatin, and Fluorouracil Induction Chemotherapy Followed by Chemoradiotherapy in Locally Advanced Head and Neck Cancer
- Erlotinib versus chemotherapy (CT) in advanced non-small cell lung cancer (NSCLC) patients (p) with epidermal growth factor receptor (EGFR) mutations: Interim results of the European Erlotinib Versus Chemotherapy (EURTAC) phase III randomized trial.
- Multicenter, Phase II Trial of Sunitinib in Previously Treated, Advanced Non–Small-Cell Lung Cancer
- Description and management of cutaneous side effects during cetuximab or erlotinib treatments: A prospective study of 30 patients
- Phase II study of continuous daily sunitinib dosing in patients with previously treated advanced non-small cell lung cancer
- Vegetable and fruit intake and the risk of lung cancer in women in Barcelona, Spain
- Lung cancer and cigarette smoking in women: A case‐control study in barcelona (Spain)
- Pharmacogenetics of the DNA repair pathways in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy
- An update on molecularly targeted therapies in second- and third-line treatment in non-small cell lung cancer: focus on EGFR inhibitors and anti-angiogenic agents
- Chop Chemotherapy of Intermediate and High-Grade Non-Hodgkin's Lymphoma
- Ovarian carcinoma preceded by cerebral metastasis: Review of the literature
- Long-term survival in small cell carcinoma of the lung
- Induction chemotherapy with paclitaxel plus carboplatin followed by paclitaxel with concurrent radiotherapy in stage IIIB non-small-cell lung cancer (NSCLC) patients: A phase II trial
- Lung Cancer OncoGuia
- The predictive value of 53BP1 and BRCA1 mRNA expression in advanced non-small-cell lung cancer patients treated with first-line platinum-based chemotherapy
- Cisplatin and intravenous continuous infusion of bleomycin in advanced and metastatic esophageal cancer
- Combinatory effect of BRCA1 and HERC2 expression on outcome in advanced non-small-cell lung cancer
- The Role of Anxiety and Adaptation to Illness in the Intensity of Postchemotherapy Nausea in Cancer Patients
- Phase II study of docetaxel and cisplatin in first line treatment of disseminated small cell lung cancer (SCLC): preliminary results